SIM staff asked for comment on their most recent policy papers, especially about financing new services. Concerns were raised that there be no disincentives to providing innovative new services likely to improve health and save money including care coordination and medication management. SIM was urged to finance these promising new services in the same way as promising traditional treatments. Providers are not asked to pay up front for new drugs that keep people out of the hospital, nor are the costs of those drugs subtracted from their shared savings payments. The SIM new services are also expected to improve value and should not be treated differently than other care. The SIM steering committee is creating a finance subcommittee to discuss these issues and more. The group agreed to hear reports on Medicaid’s health neighborhood pilot development at future meetings.
Note: Independent consumer advocates also submitted comments to SIM opposing any state of mind test to enforcement of under service standards.